Latest Regulatory News

Iluka Resources has updated its dividend details for the first half of 2025, confirming a fully franked dividend of 2 cents per share and announcing a Dividend Reinvestment Plan price of AUD 6.0274.

Savannah Goldfields is advancing steadily towards resuming gold production at its Georgetown plant, with environmental approvals secured and operational preparations underway for an October restart.

Trading in the Nanuk New World Fund (Currency Hedged) Active ETF has been temporarily halted, with personal trading also paused as investors await further details.

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

Altamin Limited has announced a $6.46 million capital raising via a pro rata entitlement offer to fund development of its lithium-potash Lazio Project and zinc-lead Gorno Project in Italy. The majority shareholder Victor Smorgon Group has committed strongly, underpinning the raise.

TG Metals Limited has clarified that its recent share price and volume spike is linked to Forrestania Resources acquiring a near 10% stake, while metallurgical test results are expected shortly.

Income Asset Management has resumed ASX trading after revealing a $1.5 million fraud involving a former employee, while assuring clients their assets remain secure under current custodianship.

Enegex Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant acquisition and capital raising, heightening market anticipation.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

Reece Limited has announced a $250 million off-market share buy-back priced between $11.00 and $13.00 per share, signaling confidence in its long-term strategy while maintaining financial flexibility.